1. Home
  2. WVE vs ETD Comparison

WVE vs ETD Comparison

Compare WVE & ETD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WVE
  • ETD
  • Stock Information
  • Founded
  • WVE 2012
  • ETD 1932
  • Country
  • WVE Singapore
  • ETD United States
  • Employees
  • WVE N/A
  • ETD N/A
  • Industry
  • WVE Biotechnology: Pharmaceutical Preparations
  • ETD Home Furnishings
  • Sector
  • WVE Health Care
  • ETD Consumer Discretionary
  • Exchange
  • WVE Nasdaq
  • ETD Nasdaq
  • Market Cap
  • WVE 915.6M
  • ETD 763.7M
  • IPO Year
  • WVE 2015
  • ETD 1993
  • Fundamental
  • Price
  • WVE $8.31
  • ETD $23.89
  • Analyst Decision
  • WVE Strong Buy
  • ETD Hold
  • Analyst Count
  • WVE 14
  • ETD 2
  • Target Price
  • WVE $20.79
  • ETD $28.00
  • AVG Volume (30 Days)
  • WVE 3.6M
  • ETD 246.5K
  • Earning Date
  • WVE 11-07-2025
  • ETD 10-29-2025
  • Dividend Yield
  • WVE N/A
  • ETD 7.57%
  • EPS Growth
  • WVE N/A
  • ETD N/A
  • EPS
  • WVE N/A
  • ETD 1.85
  • Revenue
  • WVE $93,946,000.00
  • ETD $607,296,000.00
  • Revenue This Year
  • WVE N/A
  • ETD $1.12
  • Revenue Next Year
  • WVE $6.26
  • ETD $3.79
  • P/E Ratio
  • WVE N/A
  • ETD $12.92
  • Revenue Growth
  • WVE N/A
  • ETD N/A
  • 52 Week Low
  • WVE $5.28
  • ETD $23.68
  • 52 Week High
  • WVE $16.74
  • ETD $32.61
  • Technical
  • Relative Strength Index (RSI)
  • WVE 56.37
  • ETD 23.72
  • Support Level
  • WVE $8.18
  • ETD $27.39
  • Resistance Level
  • WVE $9.75
  • ETD $28.21
  • Average True Range (ATR)
  • WVE 0.64
  • ETD 0.62
  • MACD
  • WVE 0.14
  • ETD -0.35
  • Stochastic Oscillator
  • WVE 48.94
  • ETD 4.66

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About ETD Ethan Allen Interiors Inc.

Ethan Allen Interiors Inc through its subsidiaries, operates as an interior design company, and a manufacturer and retailer in the home furnishings marketplace. Its product offerings include fabric chairs, beds, wallpapers, desks, and dining tables among others. The company's reportable segments are; Wholesale and Retail. The Wholesale segment is principally involved in the development of the Ethan Allen brand and encompasses all aspects of design, manufacturing, sourcing, marketing, sale, and distribution of home furnishings and accents. The Retail segment which generates maximum revenue, sells home furnishings and accents to clients through company-operated design centers. Geographically, it derives key revenue from the United States and the rest from other regions.

Share on Social Networks: